ATE130761T1 - Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung. - Google Patents

Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.

Info

Publication number
ATE130761T1
ATE130761T1 AT91913972T AT91913972T ATE130761T1 AT E130761 T1 ATE130761 T1 AT E130761T1 AT 91913972 T AT91913972 T AT 91913972T AT 91913972 T AT91913972 T AT 91913972T AT E130761 T1 ATE130761 T1 AT E130761T1
Authority
AT
Austria
Prior art keywords
hemoglobin
stable
methemoglobin
solution
oxygen carrying
Prior art date
Application number
AT91913972T
Other languages
English (en)
Inventor
Richard L Kandler
John C Spicussa
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24247779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE130761(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE130761T1 publication Critical patent/ATE130761T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT91913972T 1990-08-06 1991-07-24 Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung. ATE130761T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56278690A 1990-08-06 1990-08-06

Publications (1)

Publication Number Publication Date
ATE130761T1 true ATE130761T1 (de) 1995-12-15

Family

ID=24247779

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913972T ATE130761T1 (de) 1990-08-06 1991-07-24 Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.

Country Status (7)

Country Link
EP (1) EP0495047B1 (de)
JP (1) JP2709419B2 (de)
AT (1) ATE130761T1 (de)
CA (1) CA2067371C (de)
DE (1) DE69115011T2 (de)
DK (1) DK0495047T3 (de)
WO (1) WO1992002239A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5929031A (en) * 1995-05-02 1999-07-27 Baxter Biotech Technology Sarl Storage stable hemoglobin solutions
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
JP3466516B2 (ja) * 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
CA2444590C (en) 2001-04-18 2009-12-01 Robert L. Mcginnis Stabilized hemoglobin solutions
EP1978802A2 (de) 2006-01-24 2008-10-15 Northfield Laboratories, Inc. Polymerisiertes hämoglobinmedium und verwendung davon bei der isolierung und transplantation von inselzellen
US7504377B2 (en) 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
JP2008195656A (ja) 2007-02-14 2008-08-28 Nipro Corp 人工酸素運搬体製剤
GB201704006D0 (en) 2017-03-13 2017-04-26 Univ Essex Modified globin proteins
FR3083979B1 (fr) 2018-07-17 2024-06-14 Laurent Helewa Sac hygienique pouvant etre manipule sans contact avec son contenu

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI73386C (fi) * 1985-09-25 1987-10-09 Wihuri Oy En stark aongsteriliserbar maongskiktsfolie och daerav framstaellda foerpackningar foer fysiologiska loesningar.

Also Published As

Publication number Publication date
JPH05501729A (ja) 1993-04-02
DE69115011D1 (de) 1996-01-11
DK0495047T3 (da) 1995-12-27
CA2067371A1 (en) 1992-02-07
JP2709419B2 (ja) 1998-02-04
EP0495047B1 (de) 1995-11-29
CA2067371C (en) 1999-05-25
DE69115011T2 (de) 1996-04-18
WO1992002239A1 (en) 1992-02-20
EP0495047A1 (de) 1992-07-22

Similar Documents

Publication Publication Date Title
CA2117528A1 (en) Facilitated Oxygen Delivery in Conjunction with Hemodilution
JOHNSON et al. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion
Winslow Current status of blood substitute research: towards a new paradigm
IE842871L (en) Medium for storing blood platelets
DE69115011D1 (de) Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
WO1996014741A3 (en) Long-term blood component storage system and method
KR890009374A (ko) 침투향상 조성물
ATE218354T1 (de) Sauerstoff reduzierte wässerige faktor viii- enthaltene lösung
ATE203546T1 (de) Lagerstabile hämoglobinlösungen
PT819010E (pt) Formulacao de proteina compreendendo factor viii ou factor ix de coagulacao numa solucao aquosa
ATE194462T1 (de) Steigerung der kreatin und glykogen konzentration im muskel
FR2523956B1 (de)
Keipert et al. Effects of partial and total isovolemic exchange transfusion in fully conscious rats using pyridoxylated polyhemoglobin solution as a colloidal oxygen-delivering blood replacement fluid
FI961336L (fi) Menetelmä silmänesteiden säilömiseksi ja koostumuksia tätä varten
JPS592686A (ja) ミエロペルオキシダ−ゼの粉末製剤
WO1986000812A1 (en) A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof
US5985260A (en) Disinfection of blood and biologicals with active albumin-iodine complex
SILVA et al. Hypertonic saline resuscitation: saturated salt-dextran solutions are equally effective, but induce hemolysis in dogs
JPS646217A (en) Blood platelet protective agent for extracorporeal blood
Urbaniak Artificial blood
FUJIWARA et al. Affinity of thiamine propyl disulfide-S35 to organs
Moss et al. Polyhemoglobin and fluorocarbon as blood substitutes
Barnikol et al. Haemoglobin Hyperpolymers, a New Type of Artificial Oxygen Carrier–Concept and Current State of Development
WO1996020719A3 (en) Body fluid replacement solution

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee